Farid Abolhassani Cost-Benefit Analysis 18. Learning Objectives After working through this chapter, you will be able to: Define and give examples of health.

Slides:



Advertisements
Similar presentations
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlikeLicense. Your use of this material constitutes acceptance of that license.
Advertisements

NEW MILLENNIUM DEVELOPMENT GOALS (MDGs) - EMPLOYMENT INDICATORS.
1 Are you sure your improvements are cost-effective? Edward Broughton, PhD, MPH, PT University Research Co. April 11, 2014
INTANGIBLE COSTS OF ALCOHOL DEPENDENCY AS A PUBLIC GOOD: AN ESTIMATE FOR SWITZERLAND BASED ON CONTINGENT VALUATION SURVEY Sonia Pellegrini, Claude Jeanrenaud.
Introduction to Pharmacoeconomics
HERU is supported by the Chief Scientist Office of the Scottish Government Health Directorates and the University of Aberdeen. The author accepts full.
Benefit Cost Ratio Asso. Prof. Dr. Vanchai Rijiravanich Siam University Jan
Modeling the Market Process: A Review of the Basics
EVAL 6970: Cost Analysis for Evaluation Dr. Chris L. S. Coryn Nick Saxton Fall 2014.
RISK MANAGEMENT AND INSURANCE
Utility Assessment HINF Medical Methodologies Session 4.
317_L24, Mar 11/08, J. Schaafsma 1 Review of the Last Lecture are discussing shadow pricing in the context of cost-benefit analysis noted that shadow pricing.
Spring Valuation of Transportation Safety Value of Life Human Capital Direct Costs Output Losses Net Consumption Gross Output Willingness to Pay.
 Homework #2 due Thursday  Exam #1 on Thursday  Writing Assignment due Oct. 27th.
7 The CPI and the Cost of Living CHAPTER. 7 The CPI and the Cost of Living CHAPTER.
PPA 691 – Policy Analysis Lecture 7a-8a. Benefit-Cost Analysis.
Developing a Methodology for Cost-Benefit Analysis of GFATM Lilani Kumaranayake, Charlotte Watts and Philip Carriere.
Valuing the intangible costs of alcohol dependence A contingent valuation study Sonia Pellegrini Claude Jeanrenaud Institute for Economic and Regional.
1 Civil Systems Planning Benefit/Cost Analysis Scott Matthews Courses: and Lecture /6/2002.
1© 2013 by Nelson Education Ltd. CHAPTER TWELVE The Costs and Benefits of Training.
Valuation Methods focus on conventional market approaches Session Objectives: Identify key steps in valuing the environment Use selected methods to analyze.
 Homework #8 due Next Thursday  Group Outline due Nov. 11 (next Thurs.)
Drug and Therapeutics Committee
Chapter 4: Economic Efficiency and Cost Benefit Analysis 1.Economic Efficiency 2.Cost Benefit Analysis.
THE UK ECONOMY (MACROECONOMICS) TOPIC 2 UNEMPLOYMENT.
Health Economics & Policy 3 rd Edition James W. Henderson Chapter 4 Economic Evaluation in Health Care.
PowerPoint Presentation by Charlie Cook The University of West Alabama Longenecker Moore Petty Palich © 2008 Cengage Learning. All rights reserved. CHAPTER.
Consumer and Producer Surplus
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
The Financial Plan Chapter 2. Definitions You Need to Know Personal financial plan: specifying financial goals and describing in detail the spending,
1 Cost-effectiveness of improving medical services in low-resource settings Edward Broughton, PhD, MPH, PT University Research Co. May 21, 2014
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 14 Screening and Prevention of Illnesses and Injuries: Research Methods.
Valuing Health Effects of Air Pollution in DevelopingCountries: The Case of Taiwan* JOURNAL OF ENVIRONMENTAL ECONOMICS AND MANAGEMENT 34, 107 ]
© 2011 Pearson Education The CPI and the Cost of Living 22 When you have completed your study of this chapter, you will be able to 1 Explain what the.
Chapter 10 CBA and valuation1 CHAPTER 10 Cost-Benefit Analysis and Valuation.
PHAR 310: Pharmacoeconomics
1 Chapter 12 Benefit-Cost Analysis Framework of Benefit- Cost Analysis Evaluation of Benefits and Costs Benefit-Cost Ratios.
EVIDENCE BASED MEDICINE Health economics Ross Lawrenson.
Chapter 15.  Cost-benefit analysis much more widely used in other fields such as in environmental policy than in health field  Ethical objections.
Normative Criteria for Decision Making Applying the Concepts
Considering the Costs of MUS Interventions. Direct Costs v. Opportunity Costs Direct Costs Expenditures and investments to achieve a particular outcome.
Understanding Costs and Benefits Analysis Business Economics Fall Semester 2011 Standard A5.
Why Economics Matters Farid Abolhassani M.D. بسم الله الرحمن الرحيم.
Economic Assessment of IPM Programs Scott M. Swinton Dept. of Agricultural Economics Michigan State University 4 th National IPM Symposium, Indianapolis,
NHPA Mental Health. According to the World Health Organization, mental health is defined as a ‘state of wellbeing in which every individual realises his.
Valuing intangible costs of substance abuse in monetary terms Claude Jeanrenaud, Sonia Pellegrini IRER, University of Neuchâtel Neuchâtel October 25 th,
Ecosystem Valuation Social and Environmental Aspects Kathryn Benson CE 397 November 25, 2003.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 6: Cost-effectiveness analysis – Part.
Mohammad Aljawadi PharmD, PhD Clinical Pharmacy Department King Saud University PHCL 431 Sep, 2015.
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
PPA 723: Managerial Economics Lecture 21: Benefit/Cost Analysis 2, Valuing Benefits and Costs The Maxwell School, Syracuse University Professor John Yinger.
The Quandary of Quantifying Changes in Capital: What’s the Value of Strengthened Networks? Tonya Haigh National Drought Mitigation Center November 7, 2014.
1© 2010 by Nelson Education Ltd. Chapter Twelve The Costs and Benefits of Training.
Environmental Economics Class 4. Valuing the Environment: Methods Methodologies available for quantifying benefits and costs. Valuation techniques available.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 13: Cost-benefit analysis – Part 2.
Copyright © 2009 Pearson Addison-Wesley. All rights reserved. Chapter 3 Valuing the Environment: Methods.
Farid Abolhassani A Simple Model of Demand 3. Learning Objectives After working through this chapter, you will be able to: Define the term ‘quantity demanded’
Farid Abolhassani Equity 12. Learning Objectives After working through this chapter, you will be able to: Describe the relationship between equality and.
Farid Abolhassani Supply and Price Determination 4.
The CPI and the Cost of Living CHAPTER 6 C H A P T E R C H E C K L I S T When you have completed your study of this chapter, you will be able to 1 Explain.
EFFICIENCY by Caterina Ficiarà. We know that a society has to face different problems. To sum up, the main difficulties we can find in every nation are:
Farid Abolhassani What is economic evaluation 16.
Farid Abolhassani Risk, Uncertainty and Modelling Demand 7.
Understanding the Differences Between Benefit-Cost Analysis and Cost-Effectiveness Analysis AEA Coffee Break Demonstration October 27, 2011.
Chapter 14 Economic Analysis of Clinical and Managerial Interventions Copyright 2015 Health Administration Press.
Equivalent Ratios.
Economic Evaluation of Health Interventions Basic Concepts
Sergio Bautista-Arredondo National Institute of Public Health Mexico
Introduction to Health Insurance
Economics – Chapter 2, Section 2 Evaluating Economic Performance
Presentation transcript:

Farid Abolhassani Cost-Benefit Analysis 18

Learning Objectives After working through this chapter, you will be able to: Define and give examples of health outcomes in monetary terms Explain cost–benefit analysis Describe three ways of expressing the results of a cost– benefit analysis

Key Terms Benefit-cost ratio (BCR) Benefit-cost ratio (BCR) A way of presenting the results of a cost–benefit analysis, this is simply the benefits divided by the costs. Human capital approach Human capital approach An approach that uses wages to measure the value of productivity lost through illness. Net benefit Net benefit The benefits of an intervention minus its costs. Willingness to pay Willingness to pay (WTP) A method of measuring the value an individual places on reducing the risk of developing a health problem or gaining an improvement in health.

Definition monetary value of the resources monetary value of the outcomes Cost–benefit analysis (CBA) is a method of economic evaluation where the monetary value of the resources consumed by a health intervention (costs) is compared with the monetary value of the outcomes (benefits) achieved by the intervention.

How to compare costs and benefits Net benefit Net benefit – this result is expressed as a single number with monetary units; Benefit–cost ratio (BCR) Benefit–cost ratio (BCR) – this result is expressed as a ratio of benefits to costs.

Measuring benefits in monetary terms Changes in the cost of illness Willingness to pay (WTP) surveys.

Classification of Costs Total Cost of Illness Direct CostsIndirect Costs Health careNon-health care Value of lost productive time Intangible Costs PatientCaregiverRecurrentCapital ConsumablesRunning cost

Human Capital Approach Measuring the value of lost productivity by wages The value of productivity lost is then equated to wage multiplied by the time missed the wage multiplied by the time missed. Measuring the value of lost productivity by wages The value of productivity lost is then equated to wage multiplied by the time missed the wage multiplied by the time missed.

Reservations about the use of the human capital measure Is it equitable? Is it equitable? High-wage workers will be deemed to have higher indirect benefit than low-wage workers The value of non-market time: The value of non-market time: The human capital measure undervalues the work of housewives and retired people Intangible costs not included: Intangible costs not included: Most studies on cost of illness exclude intangible costs but doing so may do severe injustice to people who suffer and their families and friends

Willingness to Pay Approach The value that an individual places on reducing their risk of developing or of treating a health problem. Through a WTP survey a representative sample of the population is asked how much they would be willing to pay to gain something The value that an individual places on reducing their risk of developing or of treating a health problem. Through a WTP survey a representative sample of the population is asked how much they would be willing to pay to gain something

Water vessels for diarrhea prevention – WTP survey Total benefit = =1225 Total cost = 80 × 10 = 800 Net benefit = 1225 – 800 = 425

Reservations about the use of the WTP approach The WTP will be affected by the level of education and understanding about the causes of illness and by how important a health problem it is believed to be Where a third party pays for health care, the respondents may not have an accurate idea of what illness costs The estimates are based on what people say they will do – not what they actually do

Valuing benefits resulting from reduction in mortality Many people are unwilling and often feel it is impossible to value lives; they frequently place an infinite value on life when responding to surveys For indirect benefits, one could assume that the reduction in mortality is equivalent to lengthening of productive life and attach a value to it In WTP surveys pain and suffering reductions could be valued together with all the other attributes from the outcome of an intervention The inability or unwillingness of survey respondents to attach a value to reduced mortality has become an obstacle to the widespread use of cost–benefit analysis in health care decision making